Dr. Johan MAERTENS
Claim this profileUz Leuven
Clinical Trials Johan MAERTENS is currently running
More about Johan MAERTENS
Clinical Trial Related
3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Johan MAERTENS has experience with
- AmBisome®
- Olorofim
- CYAD-02
- ENDOXAN
- Fludara
Breakdown of trials Johan MAERTENS has run
Fungal Infection
Invasive Aspergillosis
Myelodysplastic Syndrome
Acute Myelogenous Leukemia
Acute Myeloid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Johan MAERTENS specialize in?
Johan MAERTENS focuses on Fungal Infection and Invasive Aspergillosis. In particular, much of their work with Fungal Infection has involved treating patients, or patients who are undergoing treatment.
Is Johan MAERTENS currently recruiting for clinical trials?
Yes, Johan MAERTENS is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Johan MAERTENS has studied deeply?
Yes, Johan MAERTENS has studied treatments such as AmBisome®, Olorofim, CYAD-02.
What is the best way to schedule an appointment with Johan MAERTENS?
Apply for one of the trials that Johan MAERTENS is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.